Effect of Repeating Low Intensity Extracorporeal Shock Wave Treatment (LI-ESWT) for Erectile Dysfunction (ED)
Low Intensity Extracorporeal Shock Wave Treatment (LI-ESWT) in Patients With Vasculogenic Erectile Dysfunction (ED): Evaluation of the Efficacy of Re-treatment.
1 other identifier
interventional
36
1 country
1
Brief Summary
The present study evaluates the efficacy and safety of repetitive treatments of Low Intensity Extracorporeal Shock Wave Treatment (LI-ESWT) using Aries ED device in men with mild-moderate and severe vasculogenic ED, who have previously responded to oral PDE5-Is, and completed 6 or 12 sessions of LI-ESWT with Aries device during the last 6 month.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 9, 2016
CompletedFirst Submitted
Initial submission to the registry
March 20, 2017
CompletedFirst Posted
Study publicly available on registry
March 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 4, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 4, 2017
CompletedNovember 14, 2017
November 1, 2017
11 months
March 20, 2017
November 12, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The percent of subjects who achieve clinically important difference (MCID) in the EF domain score of the IIEF
MCID is defined according to baseline ED severity as: * Improvement by 2 or more in the EF domain score of the IIEF for patients with mild ED ( EF scores 17-25) at baseline. * Improvement by 5 or more in the EF domain score of the IIEF for patients with moderate ED(EF scores 11-16) at baseline * Improvement by 7 or more in the EF domain score of the IIEF for patients with severe ED (EF scores 0-10) at baseline
at 6 month follow up visit.
Secondary Outcomes (4)
Change in the EF domain score of the IIEF
baseline and 6 month follow up visit
Change in Sexual Encounter Profile Question 3 (SEP3) score
baseline and 6 month follow up visit
Change in mean peak systolic velocity (PSV)
baseline and 3 month follow up visit
Number of patients with treatment related adverse events
27 months (Group A) ,30 months (Group B)
Study Arms (2)
Group A
ACTIVE COMPARATORPatients will receive two sessions of LI-ESWT per week for a 3 week period (6 sessions totally)
Group B
ACTIVE COMPARATORPatients will receive one session of LI-ESWT per week for a 6 week period (6 sessions totally)
Interventions
The Dornier Aries-ED device will be used for the purpose of the study. LI-ESWT will be applied to the penile shaft 3 areas, and the 2 crura (two sites).
Eligibility Criteria
You may qualify if:
- Consent to participate
- Age \>18
- Presence of vasculogenic erectile dysfunction for at least 6 months
- Positive response to PDE5i
- Patients who completed the 6 months follow-up of a previous study including 6 or 12 sessions of LI-ESWT with Aries device and still have an abnormal IIEF ED domain (\< 26)
- Abnormal penile triplex-based hemodynamic parameters (peak flow velocity \<35cm/sec)
- Stable heterosexual relationship for more than 3 months
- Sexually active and agree to suspend all ED therapy for the duration of study
You may not qualify if:
- Any cause of ED other than vascular related
- Previous radiation therapy to pelvis
- History of radical prostatectomy
- Clinically significant chronic haematological disease
- Cardiovascular conditions that prevent sexual activity
- Peyronie's Disease or penile curvature
- History of heart attack, stroke or any life- threatening arrhythmia within the prior 6 month
- Anti-androgens oral or injectables androgens
- Untreated Hypogonadism as demonstrated by abnormal testosterone levels
- Malignancy within the past 5 years
- Any unstable medical, psychiatric condition or spinal cord injury
- Anatomical or neurological abnormalities in the treatment area
- Use of any treatment for ED within 7 days of screening ( oral medications, vacuum devices, constrictive devices, injections or urethral suppositories)
- Known allergy to ultrasound gel
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
G.Gennimatas Hospital
Thessaloniki, 54621, Greece
Related Publications (5)
Lu Z, Lin G, Reed-Maldonado A, Wang C, Lee YC, Lue TF. Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis. Eur Urol. 2017 Feb;71(2):223-233. doi: 10.1016/j.eururo.2016.05.050. Epub 2016 Jun 16.
PMID: 27321373BACKGROUNDClavijo RI, Kohn TP, Kohn JR, Ramasamy R. Effects of Low-Intensity Extracorporeal Shockwave Therapy on Erectile Dysfunction: A Systematic Review and Meta-Analysis. J Sex Med. 2017 Jan;14(1):27-35. doi: 10.1016/j.jsxm.2016.11.001. Epub 2016 Dec 13.
PMID: 27986492BACKGROUNDVardi Y, Appel B, Jacob G, Massarwi O, Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol. 2010 Aug;58(2):243-8. doi: 10.1016/j.eururo.2010.04.004. Epub 2010 May 6.
PMID: 20451317BACKGROUNDGruenwald I, Kitrey ND, Appel B, Vardi Y. Low-Intensity Extracorporeal Shock Wave Therapy in Vascular Disease and Erectile Dysfunction: Theory and Outcomes. Sex Med Rev. 2013 Jul;1(2):83-90. doi: 10.1002/smrj.9. Epub 2015 Oct 18.
PMID: 27784587BACKGROUNDRosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol. 2011 Nov;60(5):1010-6. doi: 10.1016/j.eururo.2011.07.053. Epub 2011 Jul 30.
PMID: 21855209BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dimitrios Hatzichristou, Prof.
Institute for the Study of Urological Diseases (ISUD)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- President
Study Record Dates
First Submitted
March 20, 2017
First Posted
March 24, 2017
Study Start
May 9, 2016
Primary Completion
April 4, 2017
Study Completion
April 4, 2017
Last Updated
November 14, 2017
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will not share